According to 2019 self-reported date, about 7% of women reported use of prescription opioid pain relievers during pregnancy. Opioid use during pregnancy has been linked to some poor health effects for both mothers and their babies. Maternal OUD has been linked to maternal death, pre-term birth, poor fetal growth, stillbirth, and birth defects. Abstinence syndrome is more predominant in NICUs because of use in pregnancy as well.
In this session, you will learn how to identify symptoms of OUD and criteria for treatment. Barriers and facilitators for treatment will be discussed along with tools to help support patients during pregnancy and postpartum.
Speaker: Alison Lynch, MD, MS, FAPA, FASAM
Cost: Free
Purpose: The purpose of this educational offering is to provide attendees with an understanding of Opioid Use Disorder (OUD). This session will provide increased awareness of the support available from healthcare and community resources for those patients suffering from OUD during pregnancy and postpartum.
Who Should Attend? Healthcare professionals, pregnant individuals and anyone who provides care or support to pregnant and/or postpartum individuals. This may include case managers, social workers, caregivers, educators, and other professionals.
Program Objectives:
- Understand Opioid Use Disorder - criteria, symptoms, and rationale for treatment
- Describe barriers and facilitators for treatment and recovery from OUD during pregnancy and postpartum
- Become familiar with tools to support people with OUD during and after pregnancy
Awhonn_Monthly_Education_-_OUD_May_22_Updated.pdf